Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Richard M. Silver, MD, in the Spotlight

Gretchen Henkel  |  Issue: December 2018  |  December 18, 2018

Other Key Recruits

Dr. Silver reviews data with PhD candidate Tanjina Akter.

Dr. Silver reviews data with PhD candidate Tanjina Akter.

Following his interests in pediatric rheuma­tology, a passion developed by his time with Dr. Ansell prior to his UCSD fellowship, Dr. Silver had long treated children, as well as adults, at MUSC. He also wanted to establish a Division of Pediatric Rheuma­tology. He had been close to the family of Natasha Ruth, MD, since her teenage years, when he treated her mother for systemic sclerosis.

Indeed, Dr. Ruth says watching Dr. Silver with her mother and being introduced to rheumatologists at MUSC fostered her own interest in rheumatology. After medical school and a pediatric residency, she narrowed her choice to pediatric rheumatology and applied to train at Cincinnati Children’s Hospital Medical Center, where a recommendation letter from Dr. Silver to the late David Glass, MD, secured her fellowship and her future employment at MUSC. (Dr. Silver’s letter included the remark that Dr. Ruth would need her pediatric training since he had a job waiting for her if she were accepted for a fellowship.) Dr. Ruth says she accecpted the challenge of starting a new Division for Pediatric Rheumatology because she knew she would have the full support of Dr. Silver and his colleagues.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

She also managed, with Dr. Silver’s help, to recruit her former mentor from Cincinnati, Murray Passo, MD, as well as Robert Warren, MD, PhD, MPH, and Mileka Gilbert, MD, PhD. The pediatric division became South Carolina’s first referral center for childhood rheumatic diseases.

Proudly, Dr. Silver says he has recruited another young physician for that division: his daughter, Kate Silver, MD, who holds a dual appointment in adult and pediatric rheumatology.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Funding Accelerates

The division established the South Carolina Inflammation and Fibrosis Center. This was funded by philanthropic contributions and a matching grant from the South Carolina SmartState Centers for Economic Excellence. (In 2002, the South Carolina General Assembly established the SmartState Program, funding it with proceeds from the South Carolina Education Lottery. The legislation authorizes the state’s three public research institutions—Clemson University, MUSC and the University of South Carolina—to use state lottery funds to create Centers of Economic Excellence in research areas that will advance South Carolina’s economy.) The philanthropic donations came first. When queried about his expertise in securing that funding, Dr. Silver attributes the donations, large and small, to grateful patients and long-lasting relationships.

Then, during application for the SmartState funding, he and his colleagues wrote their protocol noting the two diseases studied at MUSC, scleroderma and lupus, are marked by inflammation and fibrosis. They proposed, said Dr. Silver, that “We would use these two diseases that we have expertise in as prototypes for [researching] other major diseases with even greater morbidity, mortality and societal impacts.” That positioning strategy worked and resulted in the establishment of the center, as well as the endowed chairs for Drs. Tsao and Feghali-Bostwick.

Page: 1 2 3 | Single Page
Share: 

Filed under:Profiles Tagged with:Dr. Richard M. Silver

Related Articles

    A New $1 Million Endowed Chair Honors Dr. Richard M. Silver

    February 16, 2021

    The Medical University of South Carolina (MUSC), Charleston, has established a $1 million endowed chair to support world-class autoimmune research and scholarship. The Silver chair is a tribute to the distinguished career and contributions of former Rheumatology & Immunology Division Director Richard M. Silver, MD, MACR, distinguished university professor and active division member. The inaugural holder…

    The 2018 ARHP Merit Awards & ACR Distinguished Fellows

    December 18, 2018

    CHICAGO—At the 2018 ACR/ARHP Annual Meeting in October, the ACR and the ARHP honored a group of distinguished individuals who have made significant contributions to rheumatology research, education and patient care. This month, The Rheumatologist speaks with the winners of the ARHP Merit Awards about their individual contributions to advancing rheumatology. You’ll also find interviews…

    Lost and found

    The History of ACE Inhibitors in Scleroderma Renal Crisis

    February 16, 2021

    Scleroderma renal crisis is a true medical emergency in rheumatology, one that requires prompt diagnosis and treatment. Here, we review the historic introduction of the angiotensin-converting enzyme inhibitors in this context, and highlight management and key questions moving forward. Background Awareness of renal disease in scleroderma dates back many years. The revered physician William Osler…

    Diffuse Scleroderma: A 1991 Case Through the Lens of Today

    Diffuse Scleroderma: A 1991 Case Through the Lens of Today

    February 17, 2018

    The year was 1991. It was my first Tuesday as a rheumatology fellow at the University of Pittsburgh’s Presbyterian Hospital. Navigating a maze of buildings and hallways, I delivered myself to the entrance to the scleroderma clinic. Running late and not knowing whether there was a separate entrance for staff, I clicked open the door….

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences